Muscle and endocrine disorders;Pathologies endocriniennes et muscles

Revue du Rhumatisme (Edition Francaise)

Volumn 75, Issue 2, 2008, Pages 172-177

  Berthelot, Jean Marie ^a  

^a HÔTEL DIEU   (France)

Author keywords

Adrenal; Diabetes; Endocrine; Endocrinopathy; Hormonal; Hormone; Muscles; Parathyroid; Thyroid

Indexed keywords

EID: 39149083751     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rhum.2007.11.004     Document Type: Short Survey

References (43)

1. Lopez-Soriano J., Chiellini C., Maffei M., et al. Roles of skeletal muscle and PPARs ine the development and treatment of obesity. Endocrin Rev 27 (2006) 318-329
2. Goetze J.P., Friis-Hansen L., Rehfeld J.F., et al. Atrial secretion of B-type natriuretic peptide. Eur Heart J 27 (2006) 1648-1650
3. Ubogu E.E., Ruff R.L., and Kaminski H.J. Endocrine myopathies. In: Engel A.G., and Franzini-Armstrong C.F. (Eds). Myology. 3rd ed. II (2004), Mc Graw-Hill, New York 1713-1738
4. e éd. (1997), Masson, Paris p. 84-91
5. Sthaneshwar P., Prathibha R., and Yap S.F. Thyrotoxic periodic paralysis: a report of 3 Malaysian cases and a review of its pathology. Malays J Pathol 27 (2005) 29-32
6. Silva M.R., Chiamolera M.I., Kasamatsu T.S., et al. Thyrotoxic hypokaliemic periodic paralysis, an endocrine emergency: clinical and genetic features in 25 patients. Arq Bras Endocrinol Metabol 48 (2004) 196-215
7. Liu Z., Braverman L.E., and Malabanan A. Thyrotoxic periodic paralysis in a hispanic man after the administration of prednisone. Endocr Pract 12 (2006) 427-431
8. Lichtstein D.M., and Arteaga R.B. Rhabdomyolysis associated with hyperthyroidism. Am J Med Sci 332 (2006) 103-105
9. Satoyashi E., Murakami K., Kowa H., et al. Periodic paralysis in hyperthyroidism. Neurology 13 (1963) 746-752
10. Gopinath B., Musselman R., Beard N., et al. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophtalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease. Clin Exp Immunol 145 (2006) 56-62
11. Mizuno H., Sugiyama Y., Nishi Y., et al. Elevation of serum creatine kinase in response to medical treatment of Graves' disease in children. Acta Paediatr 95 (2006) 243-245
12. Lukjanowicz M., Trzcinska-Butkiewicz B., and Brzosko M. Fenofibrate-induced myopathy in a patient with undiagnosed hypothyroidism-case report and a review of the literature. Pol Arch Med Wewn 115 (2006) 45-49
13. Buschmann I.R., Bondke A., Elgeti T., et al. Positive cardiac troponin I and T and chest pain in a patient with iatrogenic hypothyroidism and no coronary artery disease. Int J Cardiol 115 (2007) e83-e85
14. Ferrando A.A., Paddon-Jones D., and Wolfe R.R. Bed rest and myopathies. Curr Opin Clin Nutr Metab Care 9 (2006) 410-415
15. Odagaki T., Noguchi Y., and Fukui T. Flexion contracture of the legs as the initial manifestation of adrenocortical insufficiency. Intern Med 42 (2003) 710-713
16. Pearen M.A., Ryall J.G., Maxwell M.A., et al. The orphan nuclear receptor. NOR-1 is a target of beta-adrenergic signalling in skeletal muscle. Endocrinology 147 (2006) 5217-5227
17. Labrie F., Luu-The V., Bélanger A., et al. Is dehydroepiandrosterone a hormone?. J Endrocrinol 187 (2005) 169-196
18. Sheffield-Moore M., and Urban R.J. An overview of the endocrinology of skeletal muscle. Trends Endocrinol Metab 15 (2004) 110-115
19. Hartgens F., and Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med 34 (2004) 513-554
20. Kraemer W.J., and Ratamess N.A. Hormonal responses and adaptations to resistance exercise and training. Sports Med 35 (2005) 339-361
21. Solomon A.M., and Bouloux P.M. Modifying muscle mass - the endocrine perspective. J Endocrinol 191 (2006) 349-360
22. Stewart C.E., and Rittweger J. Adaptative processes in skeletal muscle: molecular regulators and genetic influences. J Musculoskelet Neuronal Interact 6 (2006) 73-86
23. Argiles J.M., Lopez-Soriano J., Almendro V., et al. Cross-talk between skeletal muscle and adipose tissue: a link with obesity?. Med Res Rev 25 (2005) 49-65
24. Febbraio M.A., and Pedersen B.K. Contraction-induced myokine production and release: is skeletal muscle an endocrine organ?. Exerc Sport Sci Rev 33 (2005) 114-119
25. Williams M.B., Hernadez J., and Thomspon I. Luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength. J Urol 173 (2005) 1067-1071
26. Jorgensen J.O., Vestergaard E.T., Krag M., et al. Skeletal muscle as a metabolic target for growth hormone. Horm Res 1 Suppl. (2006) 22-25
27. McNab T.L., and Khandwala H.M. Acromegaly as an endocrine form of myopathy: case report and review of literature. Endoc Pract 11 (2005) 18-22
28. Hoffman A.R. Treatment of the adult growth hormone deficiency syndrome: directions for future research. Growth Horm IGF Res A Suppl. (2005) 48-52
29. Turken S., Cafferty M., Silverberg S.J., et al. Neuromuscular involvement in mild asymptomatic primary hyperparathyroidism. Am J Med 87 (1989) 553-557
30. Chou F.F., Lee C.H., and Lee C.T. Muscle force and bone mineral density after parathyroidectomy and subcutaneous autotransplantation for secondary hyperparathyroidism. World J Surg 23 (1999) 452-456
31. Norman A.W. Minireview:Vitamin D receptor: new assignments for an already busy receptor. Endocrinology 147 (2006) 5542-5548
32. Day J.W., and Parry G. Normocalcemic tetany abolished by calcium infusions. Ann Neurol 27 (1990) 438-440
33. Ferrando A.A., Raj D., and Wolfe R.R. Amino acid control of muscle protein turnover in renal disease. J Ren Nutr 15 (2005) 34-38
34. Micth W.E. Metabolic and clinical consequences of metabolic acidosis. J Nephrol 9 Suppl. (2006) S70-S75
35. Volpi E., Nazemi R., and Fujita S. Muscle tissue changes with aging. Curr Opin Clin Nutr Metab Care 7 (2004) 405-410
36. Sell H., Dietze-Schroeder D., and Eckel J. The adipocyte-myocyte axis in insulin resistance. Trends Endocrinol Metab 17 (2006) 416-422
37. Pulinilkunnil T., and Rodrigues B. Cardiac lipoprotein lipase : metabolic basis for diabetic heart disease. Cardiovasc Res 69 (2006) 329-340
38. Machackova J., Barta J., and Dhalla N.S. Molecular defects in cardiac myofibrillar proteins due to thyroid hormone imbalance and diabetes. Can J Physiol Pharmacol 83 (2005) 1071-1091
39. Ferre P. Adiponectin: from adipocyte to skeletal muscle. Ann Endocrinol [Paris] 1 Suppl. (2004) S36-S43
40. Ceddia R.B. Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis. Int J Obes (Lond) 29 (2005) 1175-1183
41. Schinner S., Scherbaum W.A., Bornstein S.R., et al. Molecular mechanisms of insulin resistance. Diabet Med 22 (2005) 674-682
42. Whitehead J.P., Richards A.A., Hickman I.J., et al. Adiponection-a key adipokine in the metabolic syndrome. Diabetes Obes Metab 8 (2006) 264-280
43. Ahima R.S. Adipose tissue as an endocrine organ. Obesity (Silver Spring) 5 Suppl. (2006) 242S-249S